Skip to content
healthcare.dev
Get a free key

SEREVENT DISKUS

NDC 0173-0521, salmeterol xinafoate, powder, metered, from GlaxoSmithKline LLC.

Product NDC
0173-0521
Status
Listed
Labeler
GlaxoSmithKline LLC
Dosage form
POWDER, METERED
Route
ORAL, RESPIRATORY (INHALATION)
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA020692
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0173-0521 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SALMETEROL XINAFOATE50 ug/1

Pharmacologic classes

Adrenergic beta2-Agonists [MoA]; beta2-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
0173-0521-00001730521001 INHALER in 1 CARTON (0173-0521-00) / 60 POWDER, METERED in 1 INHALER

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/12d9728e-6b5c-4aee-bfb0-745e542ed2e4

  • NADAC price for package 00173052100

    GET /v1/drugs/nadac/00173052100

Use it

Look up 0173-0521 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0173-0521 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0173-0521. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.